Clinical Pharmacology
Flexible clinical pharmacology programs that help you make critical decisions earlier

Successful delivery of high-quality results.

At a Glance

 

Our experience spans more than 30 years and more than 1,300 Phase 1 studies delivered at our clinical units in Miami (US) and Nottingham (UK).  Our programs are led by experienced project managers alongside skilled scientists and industry-leading Phase 1 physicians numbering over 15 across both sites. Our team are experts in the full suite of healthy volunteer studies, including first-in-human (FIH), drug-drug-interaction (DDI), food effect (FE), bioequivalence (BE), thorough QT (TQT) and ADME.

Our project managers lead a matrix team integrating functions, sites and stages of development. They are committed to forming strong partnerships and true collaboration.  Your Project Manager will put you, our customer, at the heart of how we deliver each project.  The team has over 200 years of collective project management experience and over 95% of our customers plan to work with Quotient again.

Accelerate your study start-up at our clinical units in Miami (US) and Nottingham (UK) with industry-leading IRB and REC/MHRA approval timelines.  Our highly experienced regulatory specialists and scientists prepare, submit, and manage your submission.  In-depth understanding of the regulatory environment, and strong collaborative relationships with key stakeholders result in a high-quality submissions and fast approvals. 

We consider our volunteers to be partners in our clinical trials.  Their safety, comfort and feedback is important to us.  We have a volunteer-centric approach, regularly engaging our volunteers to help us maintain our outstanding metrics for delivery.


Our databases comprise more than 31,500 active healthy volunteers and our dedicated recruitment and screening teams are focused on meeting the needs of your study.  Our statistics prove our success: 99 % of our studies start on time, 98 % enrol with full cohorts, and 99 % of our subjects are retained throughout.
 

We offer end-to-end clinical pharmacology services across all healthy volunteer study programs, managing every aspect.  Our expert scientific and medical teams are available to advise on the optimal design, with extensive experience in complex protocols, including multi-part, flexible, and umbrella designs.  All aspects of delivery are covered including data management, analysis and interpretation, through to generation of the clinical study report.  Our approach ensures seamless execution and delivery of high-quality results tailored to your needs, all under a single contract and led by a single project manager.

Services and Study Types

Over 30 years of expertise to successfully deliver your studies with the highest quality service and speed.

We deliver comprehensive clinical pharmacology services and the full suite of healthy volunteer studies, from exploratory to pivotal.

   Services

   Study Types

  • First in human (FIH), inc SAD / MAD
  • Bioavailability/pharmacokinetics
  • Bioequivalence (BE)
  • Biosimilars
  • Pharmacodynamic / biomarker
  • Food effect (FE)
  • Drug-drug-interaction (DDI)
  • Cardiac monitoring / Thorough QT (TQT)
  • ADME
  • Microdose / microtracer
  • Ethnobridging
DDI Studies at Quotient Sciences
Over 30 years of experience and more than 200 DDI studies completed.

Explore Our Global Clinical Pharmacology Facilities

Our Miami, FL, USA Clinical Pharmacology Unit:

  • 144-bed clinical unit
  • FDA approved
  • Database of more than 25,000 active healthy volunteers
  • On-site compounding pharmacy with clean room for sterile products (USP 795/797/800 compliant)
  • All clinical staff are life support trained as a minimum, and licensed EMTs, nurses and physicians are Advanced Life Support (ALS) certified in accordance with local guidelines

Our Nottingham, UK Clinical Pharmacology Unit:

  • 85-bed clinical unit
  • MHRA approved, including supplementary Phase 1 accreditation
  • Database of more than 6,500 active healthy volunteers
  • On-site GMP manufacturing
  • All clinical staff are life support trained as a minimum, and all medical staff are Advance Life Support (ALS) certified in accordance with local guidelines

What's new in Clinical Pharmacology?

Translational Pharmaceutics, Clinical Pharmacology, Peptides, Modified Release, Formulation Development, Dr. Andrew Lewis, Dr. Stuart Mair Exploring GLP-1 Agonists: How they work and what the future holds for this promising treatment By: Dr. Andrew Lewis
Learn More
Get in touch
Humanity can't afford to wait, so neither can we.